MD

+ Watchlist + Portfolio

Pediatrix Medical Group, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $26.22
52-Week Range: $15.70 – $27.94
Market Cap: $2.13B
P/E (TTM): 12.55
EPS (TTM): 2.09
Dividend Yield: —

Advanced Metrics

Price/Book: 2.36
PEG Ratio: 0.24
Return on Equity: 20.39%
Return on Assets: 7.11%
Gross Margin: 26.24%
Operating Margin: 13.41%
Profit Margin: 8.96%
Current Ratio: 1.32
Debt/Equity: 0.70
Total Debt: $619.96M
Free Cash Flow: $160.78M
Revenue Growth: 4.00%
Earnings Growth: 6.50%
Enterprise Value: $2.30B

MD Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$1.97B	$1.99B	$2.01B	$1.91B
Cost of Revenue	$1.50B	$1.57B	$1.56B	$1.42B
Gross Profit	$467.03M	$421.56M	$454.34M	$493.70M
Selling, General & Admin	$231.40M	$227.54M	$238.44M	$240.79M
Operating Expenses	$267.03M	$263.71M	$270.66M	$262.62M
Operating Income	$200.00M	$157.85M	$183.68M	$231.09M
EBITDA	$156.70M	$29.89M	-$28.37M	$274.22M
Pretax Income	$81.37M	-$48.36M	-$101.34M	$216.43M
Income Tax	$18.81M	$12.05M	-$2.27M	$51.04M
Net Income	$66.33M	-$60.41M	-$99.07M	$165.39M
Diluted EPS	0.79	-0.73	-1.19	1.94
Diluted Shares	84.12M	84.02M	85.87M	85.27M

MD Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$9.82M	$73.26M	$229.94M	$375.24M
Receivables	$296.79M	$279.88M	$272.60M	$242.31M
Current Assets	$427.99M	$483.45M	$639.61M	$763.51M
Total Assets	$2.35B	$2.22B	$2.15B	$2.25B
Current Liabilities	$426.98M	$388.95M	$434.11M	$458.91M
Long-Term Debt	$627.65M	$611.59M	$593.57M	$568.95M
Total Debt	$717.08M	$701.65M	$662.31M	$634.62M
Total Liabilities	$1.46B	$1.37B	$1.39B	$1.38B
Retained Earnings	-$89.06M	-$149.47M	-$248.54M	-$83.15M
Shareholders' Equity	$891.63M	$849.06M	$764.94M	$865.85M
Working Capital	$1.01M	$94.51M	$205.50M	$304.60M
Net Debt	$630.33M	$550.84M	$382.38M	$218.71M

MD Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$166.94M	$137.32M	$206.57M	$271.09M
Capital Expenditure	-$29.71M	-$33.33M	-$22.02M	-$18.46M
Free Cash Flow	$137.23M	$104.00M	$184.55M	$252.63M
Depreciation & Amortisation	$35.64M	$36.17M	$32.23M	$21.83M
Stock-Based Compensation	$16.13M	$12.32M	$11.87M	$18.05M
Investing Cash Flow	-$56.95M	-$48.18M	-$35.41M	-$18.30M
Financing Cash Flow	-$487.55M	-$25.71M	-$14.48M	-$107.49M
Share Repurchases	-$88.51M	-$919.00K	-$1.70M	-$86.68M
Net Change in Cash	-$377.57M	$63.43M	$156.68M	$145.30M

MD Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$458.36M	$468.84M	$492.88M	$493.77M	$476.20M
Cost of Revenue	$355.72M	$344.12M	$352.53M	$367.79M	$363.23M
Gross Profit	$102.64M	$124.73M	$140.35M	$125.98M	$112.96M
Selling, General & Admin	$58.60M	$55.71M	$60.79M	$65.68M	$60.27M
Operating Expenses	$63.94M	$61.03M	$66.34M	$71.31M	$66.39M
Operating Income	$38.71M	$63.70M	$74.00M	$54.67M	$46.58M
EBITDA	$42.58M	$69.41M	$102.27M	$59.97M	$53.23M
Pretax Income	$28.09M	$54.97M	$87.78M	$45.59M	$38.84M
Income Tax	$7.35M	$15.71M	$16.07M	$11.91M	$9.27M
Net Income	$20.74M	$39.26M	$71.71M	$33.68M	$29.57M
Diluted EPS	0.24	0.45	0.84	0.40	0.36
Diluted Shares	85.81M	86.85M	85.61M	84.42M	83.08M

MD Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$98.98M	$224.73M	$340.06M	$375.24M	$205.78M
Receivables	$252.80M	$246.62M	$234.94M	$242.31M	$236.99M
Current Assets	$491.67M	$613.05M	$717.20M	$763.51M	$587.03M
Total Assets	$1.99B	$2.10B	$2.20B	$2.25B	$2.07B
Current Liabilities	$271.05M	$341.04M	$392.55M	$458.91M	$442.64M
Long-Term Debt	$590.48M	$583.86M	$577.17M	$568.95M	$398.35M
Total Debt	$655.32M	$649.56M	$642.27M	$634.62M	$629.72M
Total Liabilities	$1.20B	$1.27B	$1.31B	$1.38B	$1.19B
Retained Earnings	-$227.80M	-$188.54M	-$116.83M	-$83.15M	-$53.58M
Shareholders' Equity	$789.19M	$833.75M	$890.67M	$865.85M	$878.58M
Working Capital	$220.62M	$272.01M	$324.65M	$304.60M	$144.40M
Net Debt	$513.63M	$382.82M	$262.45M	$218.71M	$384.99M

MD Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$117.46M	$137.17M	$137.28M	$114.10M	-$129.85M
Capital Expenditure	-$3.32M	-$4.51M	-$5.34M	-$5.29M	-$6.25M
Free Cash Flow	-$120.78M	$132.65M	$131.95M	$108.81M	-$136.09M
Depreciation & Amortisation	$5.33M	$5.31M	$5.55M	$5.63M	$6.12M
Stock-Based Compensation	$3.64M	$3.91M	$5.15M	$5.34M	$4.66M
Investing Cash Flow	-$7.46M	-$7.15M	$6.60M	-$10.28M	-$11.98M
Financing Cash Flow	-$6.04M	-$4.26M	-$28.56M	-$68.64M	-$27.64M
Share Repurchases	-$1.57M	-$209.00K	-$20.87M	-$64.04M	-$21.45M
Net Change in Cash	-$130.96M	$125.75M	$115.33M	$35.18M	-$169.46M

Market Snapshot

About

Pediatrix Medical Group, Inc. provides physician services specializing in neonatal, maternal-fetal, and pediatric subspecialty care across hospitals and outpatient clinics nationwide.